Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis<sup>1</sup>

Emerg Infect Dis. 2021 Sep 14;27(11). doi: 10.3201/eid2711.211174. Online ahead of print.


We performed an observational study to investigate intensive care unit incidence, risk factors, and outcomes of coronavirus disease-associated pulmonary aspergillosis (CAPA). We found 10%-15% CAPA incidence among 823 patients in 2 cohorts. Several factors were independently associated with CAPA in 1 cohort and mortality rates were 43%-52%.

PMID:34519638 | DOI:10.3201/eid2711.211174

Source: Industry